From Naproxen Repurposing to Naproxen Analogues and Their Antiviral Activity against Influenza A Virus - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Journal of Medicinal Chemistry Année : 2018

From Naproxen Repurposing to Naproxen Analogues and Their Antiviral Activity against Influenza A Virus

Gloria Zedda
  • Fonction : Auteur
Mohamad Chebbo
  • Fonction : Auteur
Magali Noiray

Résumé

The nucleoprotein (NP) of influenza A virus (IAV) required for IAV replication is a promising target for new antivirals. We previously identified by in silico screening naproxen being a dual inhibitor of NP and cyclooxygenase COX2, thus combining antiviral and anti-inflammatory effects. However, the recently shown strong COX2 antiviral potential makes COX2 inhibition undesirable. Here we designed and synthesized two new series of naproxen analogues called derivatives 2, 3, and 4 targeting highly conserved residues of the RNA binding groove, stabilizing NP monomer without inhibiting COX2. Derivative 2 presented improved antiviral effects in infected cells compared to that of naproxen and afforded a total protection of mice against a lethal viral challenge. Derivative 4 also protected infected cells challenged with circulating 2009-pandemic and oseltamivir-resistant H1N1 virus. This improved antiviral effect likely results from derivatives 2 and 4 inhibiting NP-RNA and NP-polymerase acidic subunit PA N-terminal interactions.

Dates et versions

hal-02077007 , version 1 (22-03-2019)

Identifiants

Citer

Sebastien Dilly, Aurelien Fotso Fotso, Nathalie Lejal, Gloria Zedda, Mohamad Chebbo, et al.. From Naproxen Repurposing to Naproxen Analogues and Their Antiviral Activity against Influenza A Virus. Journal of Medicinal Chemistry, 2018, 61 (16), pp.7202-7217. ⟨10.1021/acs.jmedchem.8b00557⟩. ⟨hal-02077007⟩
73 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More